24,180 Shares in Astera Labs, Inc. $ALAB Bought by Lisanti Capital Growth LLC

Lisanti Capital Growth LLC acquired a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 24,180 shares of the company’s stock, valued at approximately $2,186,000.

Other large investors have also recently made changes to their positions in the company. Vanguard Group Inc. grew its position in Astera Labs by 0.9% during the first quarter. Vanguard Group Inc. now owns 9,297,476 shares of the company’s stock valued at $554,780,000 after buying an additional 85,846 shares during the period. Alliancebernstein L.P. boosted its stake in Astera Labs by 114.2% in the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after acquiring an additional 4,478,741 shares during the last quarter. Atreides Management LP raised its stake in shares of Astera Labs by 153.3% in the first quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after buying an additional 2,815,614 shares during the period. Fred Alger Management LLC raised its holdings in Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock valued at $93,087,000 after acquiring an additional 179,638 shares during the period. Finally, FengHe Fund Management Pte. Ltd. bought a new stake in shares of Astera Labs during the second quarter valued at about $106,772,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. Morgan Stanley upped their price objective on shares of Astera Labs from $200.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday. Wall Street Zen raised Astera Labs from a “hold” rating to a “buy” rating in a research note on Monday, November 3rd. Jefferies Financial Group raised their price target on Astera Labs from $95.00 to $130.00 and gave the company a “buy” rating in a report on Tuesday, July 22nd. TD Cowen decreased their target price on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a research report on Wednesday. Finally, Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective on the stock. in a research note on Tuesday, July 22nd. Thirteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $181.59.

Astera Labs Stock Performance

Shares of ALAB opened at $165.49 on Friday. The stock has a market capitalization of $27.95 billion, a PE ratio of 149.09, a PEG ratio of 3.68 and a beta of 1.37. Astera Labs, Inc. has a fifty-two week low of $47.13 and a fifty-two week high of $262.90. The company has a 50 day moving average price of $195.98 and a 200-day moving average price of $140.54.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.The firm’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities research analysts forecast that Astera Labs, Inc. will post 0.34 EPS for the current year.

Insider Buying and Selling

In other Astera Labs news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total transaction of $31,708,410.00. Following the completion of the transaction, the director directly owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. This trade represents a 32.17% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, COO Sanjay Gajendra sold 91,441 shares of the company’s stock in a transaction on Monday, August 18th. The shares were sold at an average price of $183.51, for a total transaction of $16,780,337.91. Following the completion of the sale, the chief operating officer directly owned 2,170,877 shares in the company, valued at $398,377,638.27. This trade represents a 4.04% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 534,480 shares of company stock worth $97,000,380 in the last quarter. 12.50% of the stock is currently owned by corporate insiders.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.